Company intelligence / Profile preview

Xendo Drug Development

Leiden, South Holland, Netherlands

Ownership: Private
Employees: ~240
Development stage: Other

Overview

Xendo provided consultancy services in regulatory affairs, quality assurance, pharmacovigilance, clinical development, validation, engineering, and project management for pharmaceutical, biotech, medical device, and chemical industries. Acquired by ProPharma Group, now integrated as part of their global compliance services.

Industry: Consulting

Beyond the preview

Go deeper on Xendo Drug Development.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Xendo Drug Development.

Explore the full profile